BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15692338)

  • 1. Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker.
    Pacifico MD; Grover R; Richman PI; Daley FM; Buffa F; Wilson GD
    Plast Reconstr Surg; 2005 Feb; 115(2):367-75. PubMed ID: 15692338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.
    Pearl RA; Pacifico MD; Richman PI; Wilson GD; Grover R
    J Plast Reconstr Aesthet Surg; 2008; 61(3):265-71. PubMed ID: 17569608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: assessment by the use of tissue microarray.
    Pacifico MD; Grover R; Richman PI; Daley FM; Buffa F; Wilson GD
    Int J Cancer; 2006 Mar; 118(6):1460-4. PubMed ID: 16187282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. nm23 as a prognostic marker in primary cutaneous melanoma: evaluation using tissue microarray in a patient group with long-term follow-up.
    Pacifico MD; Grover R; Richman PI; Buffa F; Daley FM; Wilson GD
    Melanoma Res; 2005 Oct; 15(5):435-40. PubMed ID: 16179871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
    Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
    Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel node biopsy status is strongly predictive of survival in cutaneous melanoma: Extended follow-up of Oxford patients from 1998 to 2014.
    Thomson DR; Rughani MG; Kuo R; Cassell OCS
    J Plast Reconstr Aesthet Surg; 2017 Oct; 70(10):1397-1403. PubMed ID: 28625757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microphthalmia transcription factor in malignant melanoma predicts occult sentinel lymph node metastases and survival.
    Naffouje S; Naffouje R; Bhagwandin S; Salti GI
    Melanoma Res; 2015 Dec; 25(6):496-502. PubMed ID: 26317170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
    Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
    Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma long non-coding RNA signature predicts prognostic survival and directs clinical risk-specific treatments.
    Chen X; Guo W; Xu XJ; Su F; Wang Y; Zhang Y; Wang Q; Zhu L
    J Dermatol Sci; 2017 Mar; 85(3):226-234. PubMed ID: 27955882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative.
    Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
    Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
    Keijzer R; Bril H; van der Loo EM; de Graaf PW
    Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
    Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
    Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
    van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
    Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients].
    de Vries M; Jager PL; Suurmeijer AJ; Plukker JT; van Ginkel RJ; Hoekstra HJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1845-51. PubMed ID: 16128183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sentinel lymph node status is the most important prognostic factor in patients with melanoma of the scalp.
    Cappello ZJ; Augenstein AC; Potts KL; McMasters KM; Bumpous JM
    Laryngoscope; 2013 Jun; 123(6):1411-5. PubMed ID: 23625541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.